(Q48959377)

17 February 2018

title

Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. (English)

1 reference

17 February 2018

author name string

Lynch JR

1

1 reference

17 February 2018

Morgan D

2

1 reference

17 February 2018

Mance J

3

1 reference

17 February 2018

Matthew WD

4

1 reference

17 February 2018

Laskowitz DT

5

1 reference

17 February 2018

publication date

1 March 2001

1 reference

17 February 2018

Journal of Neuroimmunology

published in

1 reference

17 February 2018

volume

114

1 reference

17 February 2018

issue

1-2

1 reference

17 February 2018

page(s)

107-113

1 reference

17 February 2018

ApoE genotype and survival from intracerebral haemorrhage

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Microglial activation in Alzheimer disease: Association with APOE genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E suppresses glial cell secretion of TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Quantitative changes in interleukin proteins following focal stroke in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a omega-agatoxin IVa-sensitive Ca2+-channel.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E: structure-function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900459-8

7 January 2021

10.1016/S0165-5728(00)00459-8

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11240021

1 reference

17 February 2018